Rockefeller Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
Rockefeller Capital Management's FBT Position: Q3 2026 in Review
Rockefeller Capital Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.54% in Q3 2026, buying an estimated $19.8K and bringing the position to 14,183 shares worth $3.86M. The position accounts for 0.01% of the portfolio, ranked #1114.
Rockefeller Capital Management first reported a position in FBT in Q1 2019 and has held it in 23 quarters since. 350 funds tracked by Wall St. Rank hold FBT as of Q3 2026.
- Rockefeller Capital Management held 14,183 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.86M as of Q3 2026.
- Rockefeller Capital Management bought 76 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $19.8K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #1114 holding.
- Rockefeller Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 23 quarters since.
- 350 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.